Home > Healthcare > Immunohistochemistry Market > Table of Contents

Immunohistochemistry Market Size, Share and Industry Analysis Report, Regional Outlook, Growth Potential, Competitive Market Share & Forecast, 2024 – 2032

  • Report ID: GMI5542

Report Content

Chapter 1   Methodology

1.1    Methodology

1.2    Market definition

1.3    Forecast parameters

1.4    Data sources

1.4.1    Secondary

1.4.1.1   Paid sources

1.4.1.2   Unpaid sources

1.4.2    Primary

Chapter 2   Executive Summary

2.1    Immunohistochemistry market, 2018 - 2032

2.1.1    Business trends

2.1.2    Product trends

2.1.3    Application trends

2.1.4    End User trends

2.1.5    Regional trends

Chapter 3   Immunohistochemistry Market Insights

3.1    Industry segmentation

3.2    Industry landscape, 2018 - 2032

3.3    Industry impact forces

3.3.1    Growth drivers

3.3.1.1   Increasing prevalence of chronic and infectious diseases

3.3.1.2   Advancement in technologies

3.3.2    Industry pitfalls & challenges

3.3.2.1   High degree of consolidation

3.3.2.2   Lack of skilled professionals

3.4    Growth potential analysis

3.4.1    By product

3.4.2    By application

3.4.3    By end user

3.5    COVID-19 impact analysis

3.6    Immunohistochemistry framework

3.7    Technology landscape

3.8    Porter’s analysis

3.8.1    Industry rivalry

3.8.2    Buyer power

3.8.3    Supplier power

3.8.4    Threat of substitute

3.8.5    Threat of new entrants

3.9    PESTEL analysis

3.9.1    Political

3.9.2    Economical

3.9.3    Social

3.9.4    Technological

3.9.5    Environmental

3.9.6    Legal

Chapter 4   Competitive Landscape, 2022

4.1    Introduction

4.2    Company matrix analysis

4.3    Company market share analysis

4.4    Strategic dashboard

Chapter 5   Immunohistochemistry Market, By Product

5.1    Key segment trends

5.2    Antibody

5.2.1    Market size, by region, 2018 - 2032 (USD Million)

5.2.2    Primary antibody

5.2.2.1   Market size, by region, 2018 - 2032 (USD Million)

5.2.3    Secondary antibody

5.2.3.1   Market size, by region, 2018 - 2032 (USD Million)

5.3    Reagents

5.3.1    Market size, by region, 2018 - 2032 (USD Million)

5.3.2    Histological stains

5.3.2.1   Market size, by region, 2018 - 2032 (USD Million)

5.3.3    Blocking sera and reagents

5.3.3.1   Market size, by region, 2018 - 2032 (USD Million)

5.3.4    Chromogenic substrate

5.3.4.1   Market size, by region, 2018 - 2032 (USD Million)

5.3.5    Diluents

5.3.5.1   Market size, by region, 2018 - 2032 (USD Million)

5.3.6    Fixation reagents

5.3.6.1   Market size, by region, 2018 - 2032 (USD Million)

5.3.7    Organic solvents

5.3.7.1   Market size, by region, 2018 - 2032 (USD Million)

5.3.8    Proteolytic enzymes

5.3.8.1   Market size, by region, 2018 - 2032 (USD Million)

5.3.9    Other reagents

5.3.9.1   Market size, by region, 2018 - 2032 (USD Million)

5.4    Equipment

5.4.1    Market size, by region, 2018 - 2032 (USD Million)

5.4.2    Slide staining systems

5.4.2.1   Market size, by region, 2018 - 2032 (USD Million)

5.4.3    Tissue processing systems

5.4.3.1   Market size, by region, 2018 - 2032 (USD Million)

5.4.4    Slide scanners

5.4.4.1   Market size, by region, 2018 - 2032 (USD Million)

5.4.5    Other equipment

5.4.5.1   Market size, by region, 2018 - 2032 (USD Million)

5.5    Kits

5.5.1    Market size, by region, 2018 - 2032 (USD Million)

5.5.2    Kits for animal tissue

5.5.2.1   Market size, by region, 2018 - 2032 (USD Million)

5.5.3    Kits for human tissue

5.5.3.1   Market size, by region, 2018 - 2032 (USD Million)

Chapter 6   Immunohistochemistry Market, By Application

6.1    Key segment trends

6.2    Diagnosis

6.2.1    Market size, by region, 2018 - 2032 (USD Million)

6.2.2    Infectious diseases

6.2.2.1   Market size, by region, 2018 - 2032 (USD Million)

6.2.3    Neurological diseases

6.2.3.1   Market size, by region, 2018 - 2032 (USD Million)

6.2.4    Nephrological diseases

6.2.4.1   Market size, by region, 2018 - 2032 (USD Million)

6.2.5    Autoimmune diseases

6.2.5.1   Market size, by region, 2018 - 2032 (USD Million)

6.2.6    Cancer

6.2.6.1   Market size, by region, 2018 - 2032 (USD Million)

6.2.7    Other diagnostic applications

6.2.7.1   Market size, by region, 2018 - 2032 (USD Million)

6.3    Research Application

6.3.1    Market size, by region, 2018 - 2032 (USD Million)

6.3.2    Drug testing

6.3.2.1   Market size, by region, 2018 - 2032 (USD Million)

6.3.3    Other research applications

6.3.3.1   Market size, by region, 2018 - 2032 (USD Million)

6.4    Forensic

6.4.1    Market size, by region, 2018 - 2032 (USD Million)

Chapter 7   Immunohistochemistry Market, By End User

7.1    Key segment trends

7.2    Hospital & diagnostics laboratories

7.2.1    Market size, by region, 2018 - 2032 (USD Million)

7.3    Research and academic institutes

7.3.1    Market size, by region, 2018 - 2032 (USD Million)

7.4    Other end users

7.4.1    Market size, by region, 2018 - 2032 (USD Million)

Chapter 8   Immunohistochemistry Market, By Region

8.1    Key regional trends

8.2    North America

8.2.1    U.S.

8.2.2    Canada

8.3    Europe

8.3.1    Germany

8.3.2    France

8.3.3    Italy

8.3.4    Spain

8.3.5    Rest of Europe

8.4    Asia Pacific

8.4.1    China

8.4.2    Japan

8.4.3    India

8.4.4    Australia

8.4.5    Rest of Asia Pacific

8.5    Latin America

8.5.1    Brazil

8.5.2    Mexico

8.5.3    Rest of Latin America

8.6    MEA

8.6.1    South Africa

8.6.2    Saudi Arabia

8.6.3    Rest of MEA

Chapter 9   Company Profiles

9.1    Thermo Fisher Scientific Inc.

9.1.1    Business overview

9.1.2    Financial data

9.1.3    Product landscape

9.1.4    Strategic outlook

9.1.5    SWOT analysis

9.2    Merck KGaA

9.2.1    Business overview

9.2.2    Financial data

9.2.3    Product landscape

9.2.4    Strategic outlook

9.2.5    SWOT analysis

9.3    F. Hoffmann-La Roche Ltd.

9.3.1    Business overview

9.3.2    Financial data

9.3.3    Product landscape

9.3.4    Strategic outlook

9.3.5    SWOT analysis

9.4    Danaher Corporation

9.4.1    Business overview

9.4.2    Financial data

9.4.3    Product landscape

9.4.4    Strategic outlook

9.4.5    SWOT analysis

   

   

9.5    Perkinelmer, Inc.

9.5.1    Business overview

9.5.2    Financial data

9.5.3    Product landscape

9.5.4    Strategic outlook

9.5.5    SWOT analysis

9.6    Bio-Rad Laboratories, Inc.

9.6.1    Business overview

9.6.2    Financial data

9.6.3    Product landscape

9.6.4    Strategic outlook

9.6.5    SWOT analysis

9.7    Cell Signaling Technology, Inc.

9.7.1    Business overview

9.7.2    Financial data

9.7.3    Product landscape

9.7.4    Strategic outlook

9.7.5    SWOT analysis

9.8    Bio SB

9.8.1    Business overview

9.8.2    Financial data

9.8.3    Product landscape

9.8.4    Strategic outlook

9.8.5    SWOT analysis

9.9    Agilent Technologies, Inc.

9.9.1    Business overview

9.9.2    Financial data

9.9.3    Product landscape

9.9.4    Strategic outlook

9.9.5    SWOT analysis

9.10    Abcam plc.

9.10.1    Business overview

9.10.2    Financial data

9.10.3    Product landscape

9.10.4    Strategic outlook

9.10.5    SWOT analysis
 

Authors: Mariam Faizullabhoy

Pre Book Now